Latest News about ABBV
Recent news which mentions ABBV
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
From Benzinga
From Benzinga
3 Stocks Retirees Should Absolutely Love
August 10, 2024
From Motley Fool
Warren Buffett's Approach To Investing In Election Years
August 07, 2024
From Benzinga
AbbVie, Leidos, KKR And More On CNBC's 'Final Trades'
August 06, 2024
From Benzinga
Worried About a Market Correction? 2 High-Yield Dividend Stocks You Can Buy Now and Hold Forever.
August 05, 2024
From Motley Fool
From Benzinga
8 Health Care Stocks With Whale Alerts In Today's Session
August 01, 2024
From Benzinga
From InvestorPlace
7 Stocks Set for a Major Bull Run
July 31, 2024
From InvestorPlace
From InvestorPlace
Bristol Myers, Johnson & Johnson, AbbVie, AstraZeneca Expect Minimal Impact From Upcoming Medicare Price Negotiations
July 30, 2024
From Benzinga
3 High-Yield Dividend Stocks That Are Looking Super Hot
July 29, 2024
From InvestorPlace
From InvestorPlace
AbbVie Wins Analyst Confidence with Q2 Beat, Diverse Portfolio Fuels Long-Term Growth Expectations
July 26, 2024
From Benzinga
From Benzinga
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
July 25, 2024
From Benzinga
Tickers
ABBV
From InvestorPlace
From InvestorPlace
AbbVie's Q2 Earnings Beat Estimates, Raises Annual Profit On Strong Sales From Newer Immunology And Cancer Drugs
July 25, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.